Reaction
Polypoidal Choroidal Vasculopathy reporting signals
As of the last recalculation, Polypoidal Choroidal Vasculopathy appears in 307 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 1,442.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 199 | 1,442.8 | 1,453.8 |
| Aflibercept | 105 | 346.3 | 347.4 |
| Faricimab | 5 | 42.5 | 42.5 |